Zealand Pharma Hosts Conference Call on August 17 at 2pm CET (8am ET) to Present First Half 2023 Results
Press Release – No. 9 / 2023 Zealand Pharma Hosts Conference Call on August 17…
News
binx health Announces Time and Motion Study Data Shared at STI & HIV 2023 World Congress in Chicago, IL
Results demonstrate that clinical staff’s hands-on-time for the binx io CT/NG point-of-care (POC) test is…
Hertz Lithium Acquires Option to Acquire Patriota Lithium Project in the Aracuai Pegmatite District
HIGHLIGHTS: Hertz has entered into an assignment agreement pursuant to which it has acquired the…
SinoMab Announces that IND Application of SM17 for the Treatment of Asthma was Approved by NAMP
HONG KONG, Aug 14, 2023 – (ACN Newswire) – A Hong Kong-based biopharmaceutical company dedicated…
CorEnergy Announces Second Quarter 2023 Results
KANSAS CITY, Mo.–(BUSINESS WIRE)–$CORR–CorEnergy Infrastructure Trust, Inc. (NYSE: CORR, CORRPrA) (“CorEnergy” or the “Company”) today…
Shapeways Reports Second Quarter 2023 Results
– Released several new software features, contributing to a 40% quarter over quarter increase in…
Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update
Strong start for Omisirge® (omidubicel-onlv) launch with significant payer coverage and number of transplant centers…
Fathom Digital Manufacturing Reports Second Quarter 2023 Financial Results
Second Quarter 2023 Highlights Revenue totaled $34.5 million Total orders were $38.0 million Net loss…
St. Luke’s University Health Network Safeguards Millions of Patient Records; Boosts Cyber Resilience with Rubrik and Microsoft Sentinel
Healthcare services non-profit achieves over 73 percent cost savings using Rubrik data security solutions alongside…
Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform
New automated features elevate the standard of care for NeuroStar® Advanced Therapy practices MALVERN, Pa.,…
Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform
New automated features elevate the standard of care for NeuroStar® Advanced Therapy practices MALVERN, Pa.,…
Ketabon GmbH Reports Top-Line Results from Phase 2 Trial of Take-at-Home, Oral Ketamine Option for Treatment-Resistant Depression
Lead Asset KET01, an Oral Prolonged-Release Ketamine Formulation, Demonstrated Early Improvements in Depressive Severity Key…
Ketabon GmbH Reports Top-Line Results from Phase 2 Trial of Take-at-Home, Oral Ketamine Option for Treatment-Resistant Depression
Lead Asset KET01, an Oral Prolonged-Release Ketamine Formulation, Demonstrated Early Improvements in Depressive Severity Key…
Grace Breeding Provides Summary Update on Progress Related to its Leading Programs for the First Half of the Year
– Grace Breeding’s environmentally friendly proprietary NFT biofertilizer (Maoz™) receives first approval in Brazil and…
Grace Breeding Provides Summary Update on Progress Related to its Leading Programs for the First Half of the Year
– Grace Breeding’s environmentally friendly proprietary NFT biofertilizer (Maoz™) receives first approval in Brazil and…
IMUNON Expands Scientific Advisory Board with the Addition of Dr. Sachet Shukla
Renowned scientist will advise on the development of IMUNON’s FixPlas and IndiPlas modalities in immuno-oncology…
IMUNON Expands Scientific Advisory Board with the Addition of Dr. Sachet Shukla
Renowned scientist will advise on the development of IMUNON’s FixPlas and IndiPlas modalities in immuno-oncology…
Allogene Therapeutics Appoints Earl Douglas as General Counsel
Earl Douglas General Counsel, Allogene Therapeutics SOUTH SAN FRANCISCO, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE)…
Allogene Therapeutics Appoints Earl Douglas as General Counsel
Earl Douglas General Counsel, Allogene Therapeutics SOUTH SAN FRANCISCO, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE)…
ContraFect Reports Second Quarter 2023 Financial Results and Provides Business Update
YONKERS, N.Y., Aug. 14, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…